Why Tempus AI, Inc. (TEM) stock moved
Tempus AI, Inc. (TEM) shares climbed 11.0% to $84.44 as of November 10, 2026, a sharp gain from the prior close of $76.05. BestStocks flagged the session as a major change for TEM. Below, we break down what changed for TEM, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
TEM climbed 11.0% to $84.44
Tempus AI stock rose 8.7% on November 2, 2026, following the release of third-quarter earnings that beat analyst expectations on both earnings and revenue. The company reported adjusted EPS of $0.07 per share against consensus estimates of a $0.09 loss, and Q3 revenue of $411.5 million versus consensus of $409.4 million. Growth was driven by a 32% increase in oncology test volume and a 33% surge in its Data & Applications segment revenue, with Minimal Residual Disease (MRD) test volumes rising roughly 300%. Management also raised full-year 2026 revenue guidance.
What it means for Tempus AI, Inc. investors
For Tempus AI, Inc. investors, the balance of recent signals points to a strong bullish shift. On the constructive side: Earnings beat with positive market reaction; Strong 11.0% price move. Weighing against that: Tempus AI fell 6.11% to $76.90 despite announcing 13 abstracts accepted for presentation at the European Society for Medical Oncology Congress 2026 (Business Wire). Wall Street's consensus price target sits at $77.83, implying -7.8% downside from $84.44. Over the past 90 days analysts logged 2 upgrades and 0 downgrades. BestStocks rates the overall signal quality medium (60/100). With earnings roughly 105 days out, the next report is the most likely near-term test of the move.
TEM price reaction
TEM last traded at $84.44, up $8.39 (+11.03%) from the previous close of $76.05. The session traded on 1.2× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $63.81 and $84.44, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on Tempus AI, Inc. (TEM)
The consensus analyst price target on Tempus AI, Inc. (TEM) is $77.83, 7.8% below the recent $84.44. Over the past 90 days analysts logged 2 upgrades, 15 maintains, and 0 downgrades. Here is how the bullish and bearish cases on TEM line up.
The bullish case
- The Street's most bullish target is $100.00 (+18.4%).
- 2 analyst upgrades in the past 90 days, most recently Jefferies to Hold (2026-11-03).
- Earnings beat with positive market reaction.
- Strong 11.0% price move.
- Tempus AI reported third-quarter 2026 results today, with revenue from its cancer screening business rising 23% year-over-year, per Business Wire and Barron's coverage.
The bearish case
- The consensus analyst price target of $77.83 sits 7.8% below the recent $84.44, so the average target sees limited room to run.
- The most bearish analyst target is $50.00 (-40.8%).
- Tempus AI fell 6.11% to $76.90 despite announcing 13 abstracts accepted for presentation at the European Society for Medical Oncology Congress 2026 (Business Wire).
Weighing both sides, BestStocks' composite read of recent signals is strongly bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 9, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for TEM
In-depth TEM event analyses
Frequently asked questions about TEM
Why did Tempus AI, Inc. (TEM) stock move?
Tempus AI stock rose 8.7% on November 2, 2026, following the release of third-quarter earnings that beat analyst expectations on both earnings and revenue. The company reported adjusted EPS of $0.07 per share against consensus estimates of a $0.09 loss, and Q3 revenue of $411.5 million versus consensus of $409.4 million. Growth was driven by a 32% increase in oncology test volume and a 33% surge in its Data & Applications segment revenue, with Minimal Residual Disease (MRD) test volumes rising roughly 300%. Management also raised full-year 2026 revenue guidance.
How much did TEM stock rise?
TEM gained 11.03% ($8.39) versus the prior close of $76.05, last trading at $84.44 on 1.2× average volume.
When is Tempus AI, Inc.'s next earnings date?
TEM's next earnings report is estimated for 2027-02-23 — about 105 days away.
What is the analyst price target for TEM?
The consensus analyst price target for TEM is $77.83, about 7.8% below the current $84.44. Over the past 90 days, analysts recorded 2 upgrades, 15 maintains, and 0 downgrades.
How BestStocks tracks TEM
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared TEM-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for TEM, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 10, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.